Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bedford Laboratories, a marketer of generic injectable pharmaceutical products, and a division of Ben Venue Laboratories, has launched its irinotecan HCl injection. This product is AP rated and is equivalent to Camptosar.
Subscribe to our email newsletter
Irinotecan is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. This product is available for immediate shipment nationwide.
Bedford Laboratories will supply irinotecan HCl injection as a sterile aqueous solution available in two different dosages including 40mg/2ml single dose amber vials individually boxed and 100mg/5ml single dose amber vials individually boxed.